Sign in
Download Opera News App

STOCK INVESTMENT

Why Arcturus Therapeutics Stock Is Plunging Today

Why Arcturus Therapeutics Stock Is Plunging Today

The biotech announced disappointing early stage results for its single-dose COVID-19 vaccine candidate. What happened Shares of Arcturus Therapeutics Holdings (NASDAQ:ARCT) were plunging 53.7% as of 11:16 a.m. EST on Tuesday. The huge decline came after the biotech reported data from an early-stage clinical study of COVID-19 vaccine candidate ARCT-021. So what Investors had...

Read Full Story
Arcturus Arcturus Therapeutics Arcturus Therapeutics Holdings NASDAQ Raymond James Steven Seedhouse

Top News

MIDDLE EAST POLITICS

Lack of sanctions for crown prince shows the might of Saudi Arabia

theguardian.com
Lack of sanctions for crown prince shows the might of Saudi Arabia

MIDDLE EAST POLITICS

Lack of sanctions for crown prince shows the might of Saudi Arabia

theguardian.com

US POLITICS

Progressives push to squash Senate filibuster after minimum wage defeat

politico.com
Progressives push to squash Senate filibuster after minimum wage defeat

US POLITICS

Progressives push to squash Senate filibuster after minimum wage defeat

politico.com